| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
13,833 |
13,118 |
$3.25M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,972 |
15,464 |
$1.76M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,530 |
5,154 |
$347K |
| 80053 |
Comprehensive metabolic panel |
7,142 |
6,513 |
$310K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,255 |
1,121 |
$211K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
8,496 |
7,654 |
$183K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,610 |
1,464 |
$173K |
| 85027 |
|
19,848 |
17,729 |
$165K |
| 71045 |
Radiologic examination, chest; single view |
7,587 |
7,248 |
$151K |
| 87400 |
|
5,765 |
5,602 |
$146K |
| J3490 |
Unclassified drugs |
383 |
266 |
$143K |
| 80305 |
|
1,863 |
1,754 |
$132K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
4,151 |
4,042 |
$112K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,000 |
961 |
$106K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,168 |
4,919 |
$96K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,049 |
1,028 |
$94K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
771 |
742 |
$93K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,380 |
1,319 |
$88K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
656 |
559 |
$87K |
| 80061 |
Lipid panel |
805 |
789 |
$86K |
| 82746 |
|
798 |
782 |
$65K |
| 82607 |
|
839 |
823 |
$64K |
| 80076 |
|
3,000 |
2,826 |
$51K |
| G0330 |
Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room |
84 |
74 |
$49K |
| 76801 |
|
414 |
359 |
$34K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
277 |
272 |
$30K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
14 |
14 |
$28K |
| 86756 |
|
1,017 |
993 |
$27K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
664 |
661 |
$27K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,093 |
788 |
$25K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
971 |
952 |
$25K |
| 81025 |
|
1,361 |
1,303 |
$22K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
667 |
664 |
$21K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
14 |
14 |
$18K |
| 83690 |
|
4,473 |
4,165 |
$17K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
438 |
416 |
$17K |
| 81003 |
|
2,542 |
2,319 |
$16K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
92 |
91 |
$15K |
| 30140 |
|
53 |
52 |
$15K |
| 86850 |
|
792 |
735 |
$14K |
| 84702 |
|
1,001 |
867 |
$9K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,980 |
6,551 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
359 |
356 |
$9K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
42 |
37 |
$8K |
| 82248 |
|
1,716 |
1,555 |
$7K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
182 |
172 |
$6K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
68 |
68 |
$6K |
| 82247 |
|
223 |
189 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
94 |
89 |
$5K |
| 84484 |
|
2,389 |
2,010 |
$5K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
67 |
65 |
$5K |
| 87088 |
|
860 |
828 |
$4K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
186 |
177 |
$4K |
| 85610 |
|
2,015 |
1,872 |
$3K |
| 85730 |
|
1,930 |
1,795 |
$3K |
| 86901 |
|
1,449 |
1,322 |
$3K |
| 86900 |
|
1,450 |
1,323 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
454 |
416 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
2,873 |
2,700 |
$2K |
| 83880 |
|
870 |
813 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,938 |
1,780 |
$1K |
| 76641 |
|
15 |
15 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
780 |
619 |
$834.80 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
95 |
87 |
$783.65 |
| J7050 |
Infusion, normal saline solution, 250 cc |
338 |
274 |
$705.75 |
| 83605 |
|
700 |
627 |
$672.42 |
| 74018 |
|
12 |
12 |
$565.95 |
| 87077 |
|
217 |
213 |
$537.13 |
| 82652 |
|
30 |
28 |
$525.42 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
175 |
163 |
$485.54 |
| 87040 |
|
301 |
254 |
$302.65 |
| 87430 |
|
13 |
13 |
$185.70 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
118 |
113 |
$156.97 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
876 |
764 |
$149.44 |
| 87186 |
|
96 |
94 |
$124.52 |
| 84703 |
|
54 |
53 |
$119.86 |
| 83735 |
|
135 |
121 |
$99.55 |
| 77080 |
|
12 |
12 |
$73.91 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
48 |
44 |
$52.10 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
379 |
329 |
$50.26 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
145 |
90 |
$42.58 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
25 |
24 |
$40.25 |
| J2704 |
Injection, propofol, 10 mg |
69 |
60 |
$19.91 |
| A9270 |
Non-covered item or service |
1,740 |
970 |
$0.00 |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
20 |
12 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
16 |
12 |
$0.00 |
| C1769 |
Guide wire |
12 |
12 |
$0.00 |
| 80320 |
|
12 |
12 |
$0.00 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
376 |
359 |
$0.00 |
| 82565 |
|
13 |
13 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
52 |
26 |
$0.00 |
| 84520 |
|
12 |
12 |
$0.00 |